Genetic Technologies (NASDAQ:GENE) Stock Passes Above Two Hundred Day Moving Average of $2.72

Genetic Technologies Limited (NASDAQ:GENE) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.72 and traded as high as $3.59. Genetic Technologies shares last traded at $3.36, with a volume of 41,823 shares trading hands.

Genetic Technologies Price Performance

The company has a debt-to-equity ratio of 0.02, a current ratio of 1.67 and a quick ratio of 1.55. The stock’s 50-day moving average is $2.44 and its 200 day moving average is $2.72.

Hedge Funds Weigh In On Genetic Technologies

An institutional investor recently raised its position in Genetic Technologies stock. Susquehanna International Group LLP increased its stake in Genetic Technologies Limited (NASDAQ:GENE) by 148.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 76,881 shares of the biotechnology company’s stock after purchasing an additional 45,901 shares during the period. Susquehanna International Group LLP owned approximately 0.50% of Genetic Technologies worth $70,000 as of its most recent filing with the Securities and Exchange Commission. 0.63% of the stock is owned by institutional investors.

Genetic Technologies Company Profile

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate.